Drug Safety

MHRA Alert – November 2024 Medicine Recalls and Safety Letters

MHRA November 2024 Safety Update

The MHRA has published a summary of letters and notifications issued to healthcare professionals throughout November 2024 concerning medicines and medical devices. This monthly round-up helps ensure all clinical teams remain informed of emerging safety issues and regulatory actions.

What You Need to Know

The November 2024 alert package includes:

  • Safety communications issued to healthcare professionals
  • Medicine and medical device recalls
  • Updated guidance on affected products
  • Recommended actions for clinical practice

Recommended Actions

All healthcare providers should:

  • Review the full MHRA alert for specific product names and batch numbers
  • Check your current stock against any recalled items
  • Communicate relevant updates to your clinical team
  • Follow MHRA guidance on patient management and product replacement
  • Report any adverse events or product issues via the Yellow Card scheme

Access the Full Alert

For complete details of all November 2024 communications, including specific medicines, batch numbers, and clinical guidance, visit the MHRA website.

Stay updated with First Responder for the latest regulatory alerts affecting your practice.